Working… Menu

A Study of Famitinib in Patients With Advanced or Metastatic Gastroenteropancreatic Neuroendocrine Tumor

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01994213
Recruitment Status : Terminated (The applicant decided to close the study)
First Posted : November 25, 2013
Last Update Posted : January 22, 2019
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Information provided by (Responsible Party):
Jiangsu HengRui Medicine Co., Ltd.

No Study Results Posted on for this Study
Recruitment Status : Terminated
Actual Primary Completion Date : November 2015
Actual Study Completion Date : May 2016